COVID-19 Guidance for Prison Settings
by WEPHRENEuropean Questionnaire on Drug Use among People living in Prison (EQDP) Methodological guidelines
by WEPHRENThis is the first in a series of publications in which report findings the Impact-C19P project which examines how Covid-19 impacted on the delivery and receipt of prison healthcare. Find out more about Impact-C19P here
With over 11 million people incarcerated globally, prevention and control of COVID-19 in custodial settings is a critical component of the public health response. Given the risk of rapid transmission in these settings, it is important to know what guidance existed for responding to COVID-19 in the early stages of the pandemic. We sought to identify, collate, and summarise guidance for the prevention and control of COVID-19 in custodial settings in the first six months of 2020.
Many prisoners still struggle to access hospital services despite their significant health care needs and early data suggests the pandemic has worsened access further. In this report, we consider new evidence relating to pre-existing health conditions before prison, the use of remote consultation, different ethnic groups' use of health services and the early impact of the Covid-19 pandemic.
This publication provides an overview of current knowledge and the latest developments in the field of drug use and prison in Europe.
During a COVID-19 outbreak involving the Delta variant in a highly vaccinated incarcerated population, transmission rates were high, even among vaccinated persons.